Hemophilia A

14 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Hematologic Diseases

Treatments and conditions

Hemophilia A
Treatment and conditionWhere it standsTrials
AAV2/8-HLP-FVIII-V3 for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ANB-010, dose 1 for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ANB-010, dose 2 for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ANB-010, dose 3 for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BPA prophylaxis + Factor (FVIII or FIX) prophylaxis + FITUSIRAN for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clotting factor concentrates (CFC) or bypassing agents (BPA) + EMICIZUMAB + FITUSIRAN + ANTITHROMBIN III HUMAN for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clotting factor concentrates (CFC) or bypassing agents (BPA) + FITUSIRAN + ANTITHROMBIN III HUMAN for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
efanesoctocog alfa (BIVV001) for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fidanacogene Elaparvovec for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Fitusiran for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Marstacimab for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPK-8011QQ for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SR604 for hemophilia aPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zemocimig for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.